It can be considered a prognostic factor for several tumors—overexpression of MMP2 is associated with poor prognosis in oral cancers, retinoblastoma, bladder cancer, epithelial cancer, and breast cancer [31]. This evidence concerns the gene MMP2 and urinary bladder cancer.